Thioridazine improves affective symptoms in schizophrenic patients.

Machine translation Machine translation
类别 Primary study
期刊Psychopharmacology bulletin
Year 1993
Loading references information
同意精神分裂症患者年龄从18岁到63岁不等的退出抗精神病药物治疗至少1周,随机分配接受相同的胶囊,硫利达嗪组(n = 13),吗茚酮组(n = 10),氟哌啶醇组(n = 12)最低6周。的molindone和氟哌啶醇治疗的患者相比,硫利达嗪治疗的患者均显著改善随着时间的推移,简明精神病评定量表(BPRS),汉密尔顿抑郁量表(HAM-D)的总成绩作为衡量。在BPRS评分的改善主要是由于焦虑和抑郁症状的改善。的主题没有其他措施,一个重要的例外的重量。吗茚酮的患者,平均瘦了5斤多了6个星期的治疗,而硫利达嗪的患者获得了6斤。氟哌啶醇治疗的患者没有明显的体重变化。
Epistemonikos ID: 7734e21a65f5d3ee94912630831e7b494938daca
First added on: Oct 27, 2012
Warning
This is a machine translation from an article in Epistemonikos.

Machine translations cannot be considered reliable in order to make health decisions.

See an official translation in the following languages: English

If you prefer to see the machine translation we assume you accept our terms of use